During the past decade, CHU de Nantes conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Nantes" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Allergan" with 2 trials sponsored, "Agenus Inc." with 1 trials sponsored and "PTC Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "CHU de Nantes" are "Multiple Myeloma" (3 trials), "Acute Myeloid Leukemia" (1 trials), "Advanced Melanoma" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "CHU de Nantes" in a lesser frequency.

Most popular intervention types in "CHU de Nantes" are "Drug" (12 trials), "Biological" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pomalidomide" (4 trials), "Carfilzomib" (3 trials), "Lenalidomide" (3 trials), "Bortezomib" (2 trials) and "Daratumumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Nantes" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHU de Nantes". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHU de Nantes, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Nantes, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".